Technical Analysis for TIL - Instil Bio, Inc.

Grade Last Price % Change Price Change
D 19.0 1.71% 0.32
TIL closed up 1.71 percent on Friday, April 16, 2021, on 62 percent of normal volume. The bears made the stock sink to a new 52-week low. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical TIL trend table...

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
New 52 Week Low Weakness 0.00%
New 52 Week Closing Low Bearish 1.71%
Hot IPO Pullback Bullish Swing Setup 1.71%
New 52 Week Low Weakness 1.71%
Multiple of Ten Bearish Other 1.71%
Down 3 Days in a Row Weakness 1.71%
Down 4 Days in a Row Weakness 1.71%
Down 5 Days in a Row Weakness 1.71%
Older End-of-Day Signals for TIL ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 2% 1 day ago
Down 5% 1 day ago
Down 3% 1 day ago
Fell Below Previous Day's Low 1 day ago
New 52 Week Low 1 day ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 (FOLR1) with indications, including gynecological, non-small cell lung cancer, and others. The company was incorporated in 2018 and is based in Dallas, Texas.

Sector: Other
Industry: Other
Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Oncology Cancer Immunotherapy Melanoma Non Small Cell Lung Cancer Cell Therapy Cervical Cancer Lymphocytes Head And Neck Squamous Cell Carcinoma Squamous Cell Carcinoma Tumor Infiltrating Lymphocytes

Is TIL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 29.49
52 Week Low 17.47
Average Volume 396,100
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 23.55
10-Day Moving Average 21.64
Average True Range 2.39
ADX 0.0
+DI 11.40
-DI 25.97
Chandelier Exit (Long, 3 ATRs ) 22.31
Chandelier Exit (Short, 3 ATRs ) 24.65
Upper Bollinger Band 28.53
Lower Bollinger Band 18.56
Percent B (%b) 0.04
BandWidth 42.34
MACD Line -1.88
MACD Signal Line -1.05
MACD Histogram -0.8293
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.40
Resistance 3 (R3) 21.16 20.11 21.00
Resistance 2 (R2) 20.11 19.50 20.24 20.87
Resistance 1 (R1) 19.56 19.12 19.84 19.80 20.73
Pivot Point 18.51 18.51 18.65 18.64 18.51
Support 1 (S1) 17.96 17.90 18.24 18.20 17.27
Support 2 (S2) 16.91 17.52 17.04 17.13
Support 3 (S3) 16.36 16.91 17.00
Support 4 (S4) 16.60